26 studies found for:    "hystrix-like ichthyosis with deafness" OR "Ichthyosis"
Show Display Options
Download search resultsDownload the search results for:
"hystrix-like ichthyosis with deafness" OR "Ichthyosis" (26 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed
Has Results
Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
Conditions: Atopic Dermatitis;   Ichthyosis Vulgaris
Intervention: Genetic: Buccal Swab
2 Completed Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
Condition: Ichthyosis, Lamellar
Intervention: Drug: Liarozole
3 Unknown  National Registry for Ichthyosis and Related Disorders
Conditions: Darier Disease;   Hailey-Hailey Disease;   Hyperkeratosis, Epidermolytic;   Ichthyosis;   Ichthyosis, Lamellar;   Ichthyosis, X-Linked;   Keratoderma
Intervention:
4 Recruiting A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
Condition: Ichthyosis
Intervention: Other: Observation
5 Withdrawn Novel Treatment for Syndromic Ichthyoses
Conditions: Syndromic Ichthyoses;   CHILD Syndrome;   Smith Lemli Opitz Syndrome;   Conradi Syndrome
Intervention: Drug: Lovastatin
6 Unknown  Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous
Condition: Lamellar Ichthyosis
Intervention: Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side
7 Completed Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
Condition: Ichthyosis
Intervention: Drug: monolaurin cream
8 Completed Study of Scaling Disorders and Other Inherited Skin Diseases
Conditions: Genetic Skin Disease;   Keratosis Follicularis;   Lamellar Ichthyosis
Intervention:
9 Active, not recruiting A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
Condition: Sjögren-Larsson Syndrome
Interventions: Drug: Active topical NS2 1% dermatologic cream;   Drug: Vehicle placebo 0.0% NS2 dermatologic cream
10 Recruiting Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Conditions: Atopic Dermatitis;   Eczema;   Ichthyosis Vulgaris
Intervention:
11 Recruiting Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers
Condition: Sjogren-Larsson Syndrome (SLS)
Intervention:
12 Unknown  Xeroderma Pigmentosum Patient Experiences
Condition: Xeroderma Pigmentosum
Intervention: Other: Survey Study
13 Completed Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
Conditions: Skin Cancer;   Xeroderma Pigmentosum;   Basal Cell Nevus Syndrome
Intervention:
14 Recruiting Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Conditions: Xeroderma Pigmentosum;   Melanoma;   Squamous Cell Carcinoma;   Basal Cell Carcinoma;   Skin Cancer
Intervention:
15 Unknown  T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
Condition: Precancerous Condition
Intervention: Drug: liposomal T4N5 lotion
16 Recruiting Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Conditions: Cockayne Syndrome;   Skin Cancer;   Xeroderma Pigmentosum;   Trichothiodystrophy;   Genodermatosis
Intervention:
17 Unknown  Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing
Conditions: Pressure Ulcers;   Venous Ulcers;   Diabetic Ulcers;   Chronic Ulcer of Foot;   Trauma-related Wound
Intervention: Device: Marigen Wound Dressing
18 Recruiting Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M
Conditions: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV);   Neutral Lipid Storage Disease With Myopathy (NLSD-M)
Intervention: Dietary Supplement: CNT-02
19 Recruiting Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
Conditions: Metabolism, Inborn Errors;   Lipid Metabolism, Inborn Errors;   Carbohydrate Metabolism, Inborn Errors;   Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency;   Glycogenin-1 Deficiency (Glycogen Storage Disease Type XV);   Carnitine Palmitoyl Transferase 2 Deficiency;   VLCAD Deficiency;   Medium-chain Acyl-CoA Dehydrogenase Deficiency;   Multiple Acyl-CoA Dehydrogenase Deficiency;   Carnitine Transporter Deficiency;   Neutral Lipid Storage Disease;   Glycogen Storage Disease Type II;   Glycogen Storage Disease Type III;   Glycogen Storage Disease Type IV;   Glycogen Storage Disease Type V;   Muscle Phosphofructokinase Deficiency;   Phosphoglucomutase 1 Deficiency;   Phosphoglycerate Mutase Deficiency;   Phosphoglycerate Kinase Deficiency;   Phosphorylase Kinase Deficiency;   Beta Enolase Deficiency;   Lactate Dehydrogenase Deficiency;   Glycogen Synthase Deficiency
Intervention: Other: Sugar
20 Active, not recruiting Clinical Trial Using Humira in Netherton Syndrome
Condition: Netherton Syndrome
Intervention: Drug: Adalimumab

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years